Vaccines comprising acapsular P. multocida hyaE deletion mutants
US7351416B2 · kind B2 · utility
12Cited by
2References
78Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 2, 2004 |
| Grant date | Apr 1, 2008 |
| Priority date | — |
| Expiry date | Jul 20, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/522
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Acapsular hyaE deletion mutants of P. multocida can be administered to mammals, particularly ungulates, or birds to provide protective immunity against wild-type P. multocida, e.g., to prevent or reduce the severity of hemorrhagic septicemia or pneumonia in mammals, particularly livestock, ungulates, and companion animals, or fowl cholera in birds, particularly poultry.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.